Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S C Wise

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Immunohematology|February 21, 2013
Paroxysmal cold hemoglobinuria: a case reportS C Wise, S H Tinsley, L O Cook
Immunohematology|January 1, 1997
Antibodies to low-incidence antigens and elimination of the antihuman globulin phase of the crossmatch-case report: anti-WraS C Wise, P J Larson, L O Cook
Diabetes|May 20, 1999
Troglitazone, an antidiabetic agent, inhibits cholesterol biosynthesis through a mechanism independent of peroxisome proliferator-activated receptor-gammaM Wang, S C Wise, T Leff, et al.
The Journal of Biological Chemistry|October 4, 1996
c-Jun can mediate androgen receptor-induced transactivationA Bubulya, S C Wise, X Q Shen, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|August 1, 1996
Dominant-negative mutants of cJun inhibit AP-1 activity through multiple mechanisms and with different potenciesP H Brown, S H Kim, S C Wise, et al.
Oncogene|May 20, 1998
Identification of domains of c-Jun mediating androgen receptor transactivationS C Wise, L A Burmeister, X F Zhou, et al.
Diabetes|June 28, 2000
Differential activation of peroxisome proliferator-activated receptor-gamma by troglitazone and rosiglitazoneH S Camp, O Li, S C Wise, et al.
Oncogene|November 11, 1999
cJun overexpression in MCF-7 breast cancer cells produces a tumorigenic, invasive and hormone resistant phenotypeL M Smith, S C Wise, D T Hendricks, et al.
Oncogene|December 7, 2010
AXL regulates mesothelioma proliferation and invasivenessW-B Ou, J M Corson, D L Flynn, et al.
Leukemia|August 22, 2012
Targeting the KIT activating switch control pocket: a novel mechanism to inhibit neoplastic mast cell proliferation and mast cell activationY Bai, G Bandara, E Ching Chan, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Immunohematology|February 21, 2013
Paroxysmal cold hemoglobinuria: a case reportS C Wise, S H Tinsley, L O Cook
Immunohematology|January 1, 1997
Antibodies to low-incidence antigens and elimination of the antihuman globulin phase of the crossmatch-case report: anti-WraS C Wise, P J Larson, L O Cook
Diabetes|May 20, 1999
Troglitazone, an antidiabetic agent, inhibits cholesterol biosynthesis through a mechanism independent of peroxisome proliferator-activated receptor-gammaM Wang, S C Wise, T Leff, et al.
The Journal of Biological Chemistry|October 4, 1996
c-Jun can mediate androgen receptor-induced transactivationA Bubulya, S C Wise, X Q Shen, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|August 1, 1996
Dominant-negative mutants of cJun inhibit AP-1 activity through multiple mechanisms and with different potenciesP H Brown, S H Kim, S C Wise, et al.
Oncogene|May 20, 1998
Identification of domains of c-Jun mediating androgen receptor transactivationS C Wise, L A Burmeister, X F Zhou, et al.
Diabetes|June 28, 2000
Differential activation of peroxisome proliferator-activated receptor-gamma by troglitazone and rosiglitazoneH S Camp, O Li, S C Wise, et al.
Oncogene|November 11, 1999
cJun overexpression in MCF-7 breast cancer cells produces a tumorigenic, invasive and hormone resistant phenotypeL M Smith, S C Wise, D T Hendricks, et al.
Oncogene|December 7, 2010
AXL regulates mesothelioma proliferation and invasivenessW-B Ou, J M Corson, D L Flynn, et al.
Leukemia|August 22, 2012
Targeting the KIT activating switch control pocket: a novel mechanism to inhibit neoplastic mast cell proliferation and mast cell activationY Bai, G Bandara, E Ching Chan, et al.
Pageof 1